- COVID-19 has hit the business hard given the company's focus on SMBs. We expect no growth for the rest of 2020.
- We expect any potential M&A, by which the management expects to deliver an additional 10% growth in 2020, to be put on hold.
- The long-term issue regarding weak positioning remains.
We will remain neutral on Asure Software (ASUR), considering the current pandemic-related headwinds that have severely impacted its business and its SMBs client base. The stock is down ~24% from last December when we published our first coverage on the stock. Back then, we discussed our view of the company’s limited upside potential despite the shift to pure HCM SaaS business. Today, we still hold the same view of the outlook, which is even worsened by the COVID-19.
Read the original article here
No comments:
Post a Comment